Flinton Capital Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$539K Hold
3,842
0.02% 436
2019
Q2
$703K Buy
3,842
+170
+5% +$31.1K 0.02% 391
2019
Q1
$584K Buy
3,672
+476
+15% +$75.7K 0.02% 432
2018
Q4
$306K Sell
3,196
-204
-6% -$19.5K 0.01% 551
2018
Q3
$480K Buy
3,400
+2,720
+400% +$384K 0.01% 504
2018
Q2
$106K Buy
680
+646
+1,900% +$101K ﹤0.01% 759
2018
Q1
$5K Buy
+34
New +$5K ﹤0.01% 849